Prof. Rob de Bie joins Dr. Sara Schaefer to discuss the 5-year follow up extension to the Levodopa in Early Parkinson's disease (LEAP) study, including the results and indications for practice.

<br/><a href="https://education.movementdisorders.org/detail/841/journal-cme--long-term-follow-up-of-the-leap-study-early-versus-delayed-levodopa-in-early-parkinson-s-disease">Journal CME</a> is available until July 01, 2025

<a href="https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.29796">Read the article.</a>

Prof. Rob de Bie joins Dr. Sara Schaefer to discuss the 5-year follow up extension to the Levodopa in Early Parkinson's disease (LEAP) study, including the results and indications for practice. Journal CME is available until July 01, 2025 Read the article.

Prof. Rob de Bie joins Dr. Sara Schaefer to discuss the 5-year follow up extension to the Levodopa in Early Parkinson's disease (LEAP) study, including the results and indications for practice.

<br><a href="https://education.movementdisorders.org/detail/841/journal-cme--long-term-follow-up-of-the-leap-study-early-versus-delayed-levodopa-in-early-parkinson-s-disease" rel="noopener noreferrer">Journal CME</a> is available until July 01, 2025

<a href="https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.29796" rel="noopener noreferrer">Read the article.</a>

Is levodopa disease modifying? Long-term LEAP study follow-up

Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders. Each episode of the International Parkinson and Movement Disorder Society podcast discusses a relevant development in the field, including highlighted journal articles and interviews with the authors.

Share Is levodopa disease modifying? Long-term LEAP study follow-up

Sign up to save your podcasts

Is levodopa disease modifying? Long-term LEAP study follow-up

Is levodopa disease modifying? Long-term LEAP study follow-up